Ubs Global Asset Management Americas »

Halozyme Therapeutics shares owned by Ubs Global Asset Management Americas

Quarter-by-quarter ownership of Halozyme Therapeutics (HALO) shares owned by Ubs Global Asset Management Americas from 13F filings

Historical chart of Ubs Global Asset Management Americas investment in Halozyme Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Halozyme Therapeutics held by Ubs Global Asset Management Americas consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Halozyme Therapeutics by Ubs Global Asset Management Americas

Quarter filed Position value Share count Share price at filing
2024-03-31 $6.5M 161k 40.68
2023-12-31 $6.0M 161k 36.96
2023-09-30 $6.0M 158k 38.20
2023-06-30 $13M 335k 38.19
2023-03-31 $13M 335k 38.19
2022-12-31 $30M 519k 56.90
2022-09-30 $21M 520k 39.54
2022-06-30 $7.8M 177k 44.00
2022-03-31 $6.7M 168k 39.88
2021-12-31 $6.1M 151k 40.21
2021-09-30 $6.0M 148k 40.68
2021-06-30 $7.1M 155k 45.41
2021-03-31 $6.3M 151k 41.69
2020-12-31 $3.7M 141k 26.28
2020-09-30 $3.7M 141k 26.28
2020-06-30 $3.9M 145k 26.81
2020-03-31 $16M 873k 17.99
2019-12-31 $19M 1.1M 17.73
2019-09-30 $14M 889k 15.51
2019-06-30 $2.0M 117k 17.18
2019-03-31 $1.6M 100k 16.10
2018-12-31 $1.4M 93k 14.63
2018-09-30 $1.6M 89k 18.17
2018-06-30 $1.5M 90k 16.87
2018-03-31 $1.7M 87k 19.59
2017-12-31 $1.7M 84k 20.26
2017-09-30 $1.4M 78k 17.37
2017-06-30 $1.1M 86k 12.82
2017-03-31 $879k 68k 12.96
2016-12-31 $733k 74k 9.87
2016-09-30 $1.2M 99k 12.08
2016-06-30 $838k 97k 8.64
2016-03-31 $1.1M 119k 9.46
2015-12-31 $2.2M 126k 17.33
2015-09-30 $1.5M 111k 13.41
2015-06-30 $2.1M 93k 22.57
2015-03-31 $578k 41k 14.27
2014-12-31 $371k 38k 9.66
2014-09-30 $317k 35k 9.11
2014-06-30 $336k 34k 9.88
2014-03-31 $432k 34k 12.71
2013-12-31 $510k 34k 15.00
2013-09-30 $607k 55k 11.04
2013-06-30 $2.9M 361k 7.94